Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Lymphoid 1 Genitourinary 1 CNS 1

Conditions

Brain Neoplasms 1905 Glioblastoma 1797 Glioma 1130 Central Nervous System Neoplasms 599 Astrocytoma 594 Neuroblastoma 552 Gliosarcoma 465 Oligodendroglioma 364 Neoplasms 312 Breast Neoplasms 273 Medulloblastoma 272 Carcinoma, Non-Small-Cell Lung 227 Recurrence 199 Sarcoma 184 Neoplasm Metastasis 183 Melanoma 182 Meningioma 177 Ependymoma 176 Lung Neoplasms 157 Lymphoma 134 Osteosarcoma 127 Meningeal Carcinomatosis 126 Neurofibromatosis 1 114 Wilms Tumor 111 Ovarian Neoplasms 110 Diffuse Intrinsic Pontine Glioma 105 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Rhabdomyosarcoma 101 Lymphoma, Non-Hodgkin 96 Burkitt Lymphoma 89

Interventions

nabiximols 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Marijuana Abuse × CNS × Clear all

NCT05629702 2026-05-05

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡